As of 2024-12-14, the Intrinsic Value of NOXXON Pharma NV (ALNOX.PA) is
-1.61 EUR. This ALNOX.PA valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.05 EUR, the upside of NOXXON Pharma NV is
-3,316.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-1.61 EUR
Intrinsic Value
ALNOX.PA Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-1.61 - -1.61 |
-1.61 |
-3,316.00% |
| P/E |
(2.19) - (2.63) |
(2.42) |
-4938.2% |
| DDM - Stable |
(1.75) - (7.19) |
(4.47) |
-9038.3% |
| DDM - Multi |
(0.90) - (2.97) |
(1.39) |
-2880.7% |
ALNOX.PA Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
6.81 |
| Beta |
1.83 |
| Outstanding shares (mil) |
136.11 |
| Enterprise Value (mil) |
-2.63 |
| Market risk premium |
5.23% |
| Cost of Equity |
8.80% |
| Cost of Debt |
5.00% |
| WACC |
8.79% |